'Epidermal growth factor receptors' presentation slideshows

Drug-Induced Skin Reactions

Drug-Induced Skin Reactions. Objectives. The learner will be able to: Identify cancer treatments most likely to cause drug-induced skin reactions. Discuss preventative and management strategies for various types of rashes caused by systemic cancer treatments. . Problem.

533 views • 21 slides

New Aspects of Adjuvant Therapy in Endometrial Cancer: Current Standards and Future Directions

New Aspects of Adjuvant Therapy in Endometrial Cancer: Current Standards and Future Directions. Jalid Sehouli, Dominique Koensgen, Gulten Oskay-Ozcelik, Alexander Mustea Department of Obstetrics and Gynecology, Charite University Hospital, Campus Virchow-Clinic, Berlin, Germany

496 views • 20 slides

Emerging Concepts in the Workup of Colorectal Cancer

264 views • 14 slides

Erlonat 150 mg (Natco)|Anti cancer Drug|uses,side effects,price India

Erlonat tablet has active ingredient Erlotinib, used to treat non-small cell lung cancer, pancreatic cancer and other various types of cancer. Erlonat is pharmacologically categorized as a tyrosine kinase inhibitor, acts on epidermal growth factor receptor @MHP

72 views • 6 slides

Erlocip 150mg - Anticancer drugs | view uses, side effects and price | MHP

Erlocip tablet has active ingredient Erlotinib, used to treat non-small cell lung cancer, pancreatic cancer and other various types of cancer. Erlocip is pharmacologically categorized as a tyrosine kinase inhibitor, acts on epidermal growth factor receptor. @MHP

74 views • 6 slides